US-based Eli Lilly's Kisunla drug and Japanese company Eisai's Leqembi (below), two breakthrough drugs for the diagnosis and ...
New UK study reveals daily physical activity reduces brain disease risk from dementia to depression, anxiety, stroke and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback